Phase II study of RCHOP with pegylated liposomal doxorubicin (DRCOP) for patients older than age 60 with untreated diffuse large B-cell lymphoma (DLBCL).
2011 ◽
Vol 29
(15_suppl)
◽
pp. 8053-8053
M. A. Rodriguez
◽
J. Durand
◽
A. B. Astrow
◽
M. J. Bury
◽
M. A. Fanale
◽
...